Database updated: 27 October 2026
Safety Information
Medsafe Online Recall Database
Detail of Recall
| Type of Product: | Device |
| Medsafe Reference: | 19675 |
| Brand Name: | Siemens ADVIA Centaur Enhanced Estradiol |
| Model: | 10490889 1049144510697757 |
| Affected: | All lots |
| Software version: | |
| Recalling Organisation: | Siemens Healthcare (NZ) Ltd 55 Hugo Johnston Drive Penrose Auckland |
| Contact Information: | 0800 310 300 |
| Manufacturer: | Siemens Healthcare Diagnostics Inc |
| Brand Name: | Siemens Dimension Vista LOCI Estradiol |
| Model: | K643 |
| Affected: | All lots |
| Software version: | |
| Recalling Organisation: | Siemens Healthcare (NZ) Ltd Millennium Centre, Part Level 2, Building A 600 Great South Road Ellerslie AUCKLAND 1051 |
| Contact Information: | 0800 310 300 |
| Manufacturer: | Siemens Healthcare Diagnostics Inc |
| Brand Name: | Siemens IMMULITE/ IMMULITE 1000 Estradiol |
| Model: | LKE21 LKE21 (D) |
| Affected: | All lots |
| Software version: | |
| Recalling Organisation: | Siemens Healthcare (NZ) Ltd Millennium Centre, Part Level 2, Building A 600 Great South Road Ellerslie AUCKLAND 1051 |
| Contact Information: | 0800 310 300 |
| Manufacturer: | Siemens Healthcare Diagnostics Inc |
| Brand Name: | Siemens IMMULITE 2000 Estradiol |
| Model: | L2KE22 L2KE22(D) L2KE26 L2KE26(D) |
| Affected: | All lots |
| Software version: | |
| Recalling Organisation: | Siemens Healthcare (NZ) Ltd 55 Hugo Johnston Drive Penrose Auckland |
| Contact Information: | 0800 310 300 |
| Manufacturer: | Siemens Healthcare Diagnostics Inc |
| Issue: | Manufacturer has confirmed the drug fulvestrant (Faslodec) may cause elevated estradiol results in the assays listed. Fulvestrant is used in post-menopausal women treated for oestrogen receptor positive recurent stage 1V breast cancer.If the listed estradiol assays are used to assess the menopausal status of such a patient population, falsely elevated estradiol levels could lead the clinician to misinterpret the patient as premenopausal possbly leading to altered or discontinued use of the potential beneficial drug fulvestrant. |
| Recall action type: | Correction |
| Recall action: | Manufacturer to issue advice regarding use |
| Level of recall: | Hospital/Pharmacy/Laboratory |
| Date Commenced: | 19/1/2016 |
